Table 3.
Correlations between homeostasis model assessment of insulin resistance and clinical parameters
| All | Men | Women | ||||
|---|---|---|---|---|---|---|
| r | P | r | P | r | P | |
| Age | 0.045 | 0.667 | 0.013 | 0.930 | −0.084 | 0.580 |
| Bodyweight | 0.471 | <0.001 | 0.326 | 0.024 | 0.547 | <0.001 |
| BMI | 0.511 | <0.001 | 0.393 | 0.006 | 0.612 | <0.001 |
| Waist circumference | 0.542 | <0.001 | 0.479 | 0.001 | 0.510 | <0.001 |
| Visceral fat | 0.626 | <0.001 | 0.627 | <0.001 | 0.430 | 0.003 |
| Subcutaneous fat | 0.374 | <0.001 | 0.307 | 0.034 | 0.576 | <0.001 |
| Body fat mass | 0.509 | <0.001 | 0.478 | 0.001 | 0.585 | <0.001 |
| Fat free mass | 0.299 | 0.003 | 0.006 | 0.968 | 0.301 | 0.042 |
| %Body fat | 0.374 | <0.001 | 0.565 | <0.001 | 0.534 | <0.001 |
| Systolic BP | 0.410 | <0.001 | 0.412 | 0.004 | 0.318 | 0.031 |
| Diastolic BP | 0.391 | <0.001 | 0.357 | 0.013 | 0.289 | 0.051 |
| Fasting glucose | 0.435 | <0.001 | 0.388 | 0.006 | 0.303 | 0.041 |
| HbA1c | 0.194 | 0.060 | 0.137 | 0.354 | 0.263 | 0.077 |
| Fasting insulin | 0.985 | <0.001 | 0.985 | <0.001 | 0.989 | <0.001 |
| LDL-C | 0.132 | 0.206 | 0.096 | 0.514 | 0.038 | 0.802 |
| HDL-C | −0.485 | <0.001 | −0.344 | 0.017 | −0.597 | <0.001 |
| Triglyceride | 0.595 | <0.001 | 0.618 | <0.001 | 0.303 | 0.041 |
| AST | 0.348 | 0.001 | 0.231 | 0.113 | 0.340 | 0.021 |
| ALT | 0.482 | <0.001 | 0.365 | 0.011 | 0.586 | <0.001 |
| γGT | 0.408 | <0.001 | 0.381 | 0.008 | 0.048 | 0.750 |
| Uric acid | 0.319 | 0.002 | 0.348 | 0.015 | −0.199 | 0.184 |
| Leptin | 0.392 | <0.001 | 0.621 | <0.001 | 0.792 | <0.001 |
| Adiponectin | −0.336 | 0.001 | −0.305 | 0.035 | −0.213 | 0.155 |
| hsCRP | 0.296 | 0.004 | 0.286 | 0.049 | 0.375 | 0.010 |
γGT, γ-glutamyl transpeptidase
ALT, alanine aminotransferase
AST, aspartate aminotransferase
BMI, body mass index
BP, blood pressure
HbA1c, glycated hemoglobin
HDL-C, high-density lipoprotein cholesterol
hsCRP, high-sensitivity C-reactive protein
LDL-C, low-density lipoprotein cholesterol.